Stocks · NYSE · Healthcare · United States
CRL — Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (CRL) is a healthcare stock listed on NYSE (United States). At the close of September 29, 2026 it traded at 295.96 (+0.47% on the day), +2.7% over one month, +29.2% over three months, +101.3% over twelve months. The InvestMuse composite score is +11 on a −100 to +100 scale, a mixed read that ranks #617 of about 1,221 assets. The strongest of its nine dimensions are Momentum (+94) and Trend (+54); the weakest is Fundamentals (-27). Its volatility regime from the hidden Markov model is Calm. 47 news articles in the last 30 days carried an average tone of +0.27 (on −1 to +1).
The facts
| Last close | 295.96 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +0.47% / +2.7% / +29.2% / +101.3% |
| 52-week range | 146.99 – 298.58 |
| Composite score | +11 / 100 · mixed view · rank #617 |
| Volatility regime (HMM) | Calm |
| Resistance levels | 89.00, 140.00, 200.00 |
| Market cap | $11.0B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)0
- Technical indicators-20
- Trend+54
- Support / resistance0
- Fundamentals-27
- Sector edge-21
- News sentiment+27
- Momentum+94
- Chart patterns and zones-15
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.